In this episode, we look at the integration and development of artificial intelligence (AI) into medical technologies, or as the sector is commonly referred to: Medtech.
Countries today are racing to be the global leader in AI. Just earlier this month, President Donald Trump signed the “American A.I. Initiative,” an executive order meant to stimulate the development and regulation of artificial intelligence. Last year in the UK, Prime Minister Theresa May announced a plan to revolutionize how chronic diseases are diagnosed in the country by significantly increasing the use of data and AI.
With AI technology growing ever more sophisticated and governments leaning into its use in healthcare, investment in the sector seems likely to grow. However, there are more reservations about data privacy and concerns over implementation when it comes to incorporating AI in healthcare practices.
So, we turned to healthcare experts to help guide us through the opportunities, challenges, and serious investment opportunity that AI in Medtech presents.
We would like to extend a massive thank you to our amazing guests: Dr. Robert Pearl, author of Washington Post bestseller 'Mistreated'; Dr. Jenny Barnett, Chief Scientific Officer of Cambridge Cognition; and Ariel Beery, CEO of MobileODT.
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
(Sharecast News) - London equity markets finished in positive territory on Friday, managing to break above the waterline in late trading after worries about rising Covid-19 cases and further restrictions knocked sentiment earlier in the session.
Find out in this fascinating 25mins interview, what super-smart UK smallcap fund manager Judith MacKenzie (Downing) thinks of today's equity markets, along with discussing her investment process and 5 compelling deep value/GARP stock ideas.
Bahamas Petroleum, the Caribbean and Atlantic margin focused oil and gas company has announced announce that the Stena IceMAX drill rig for the upcoming Perseverance #1 drilling campaign is expected to be on site around the 15 December. This means that Perseverance #1 would be expected to spud prior to Christmas 2020.
Prospex Energy PLC, the AIM quoted investment company, Half Year Report highlights the advancing portfolio of late stage onshore European gas projects that range from exploration through to power generation. Once the Company has achieved first gas at Selva in Italy and the transfer of a 49.9% interest in the El Romeral gas and power project to our Spanish affiliate, the Company assures investors Prospex will be a highly cash flow generative energy investment company.
(Sharecast News) - London stocks edged higher in early trade on Friday as investors mulled over the latest UK borrowing figures, but the FTSE 100 was still on course for heavy weekly losses amid ongoing concerns about the coronavirus and its impact on the economy.